Axogen Announces Award of Award to New Employee Under NASDAQ Listing Rule 5635(C)(4)

ALACHUA, Fla. and TAMPA, Fla., Sept. 3, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in the development and marketing of innovative surgical solutions for peripheral nerve injuries, today announced that it has granted an equity incentive award to a new non-executive employee under the terms of Axogen Inc.’s Inducement Equity Incentive Plan on September 3, 2024. The award was approved by the Compensation Committee of Axogen’s Board of Directors in accordance with NASDAQ Listing Rule 5635(c)(4) and was made as a material incentive for the employee’s acceptance of employment with Axogen.

The award consists of restricted stock units (“RSUs”) representing 10,000 shares of the Company’s common stock. The RSUs are subject to vesting over four years, with 50% vesting after the second year and 25% of the total shares awarded vesting each year thereafter for the next two years.